135 related articles for article (PubMed ID: 428229)
1. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.
Vose CW; Butler JK; Williams BM; Stafford JE; Shelton JR; Rose DA; Palmer RF; Breckenridge AM; Orme ML; Serlin MJ
Contraception; 1979 Feb; 19(2):119-27. PubMed ID: 428229
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
[TBL] [Abstract][Full Text] [Related]
3. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
Stanczyk FZ; Mroszczak EJ; Ling T; Runkel R; Henzl M; Miyakawa I; Goebelsmann U
Contraception; 1983 Sep; 28(3):241-51. PubMed ID: 6641224
[TBL] [Abstract][Full Text] [Related]
6. The relative expressed estrogenicity of oral contraceptives.
Rooks WH; Kugler SL; Dorfman RI
Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of norethisterone in humans.
Shi YE; He CH; Gu J; Fotherby K
Contraception; 1987 May; 35(5):465-75. PubMed ID: 3621943
[TBL] [Abstract][Full Text] [Related]
8. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
Gidwani GP; Purandare BN
J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage.
Braselton WE; Lin TJ; Ellegood JO; Mills TM; Mahesh VB
Am J Obstet Gynecol; 1979 Jan; 133(2):154-60. PubMed ID: 369375
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclic progestin-estrogen therapy on sebum and acne in women.
Strauss JS; Pochi PE
JAMA; 1964 Nov; 190(9):815-9. PubMed ID: 12254865
[TBL] [Abstract][Full Text] [Related]
11. Serum and placenta levels of ethynylestradiol in presence of ethynodiol diacetate after oral administration.
Morvay J; Altorjay I; Sas M
Horm Res; 1982; 16(4):237-43. PubMed ID: 6890038
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
de la Pena A; Chenault CB; Goldzieher JW
Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
16. Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diacetate administration.
Cooke ID; Back DJ; Shroff NE
Contraception; 1985 Jun; 31(6):611-21. PubMed ID: 4042659
[TBL] [Abstract][Full Text] [Related]
17. [Excretion of 17-hydroxycorticosteroids under the effect of combined preparations containing separate progestagens: ethynodiol diacetate and chlormadinone].
Kloś J; Radwańska E
Endokrynol Pol; 1971; 22(1):61-8. PubMed ID: 4100342
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of norethindrone and ethinyl estradiol for two different weight tablets with the same hormonal content.
Saperstein S; Edgren RA; Ellis DJ; Lee GJ; Kushinsky S; Olmsted A; Mroszczak E
Contraception; 1986 Jun; 33(6):547-57. PubMed ID: 3769481
[TBL] [Abstract][Full Text] [Related]
20. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
Goldman JA
Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
